Powers Medical Devices develops therapeutic and diagnostic feedback sensor products, which will be used to address the nutritional and distress tolerance needs of preterm, full term and critical care infants.
The company, by licensing technology from Florida State University, has developed the Pacifier Activated Lullaby (PAL) system that is used in hospitals for premature infants with feeding issues and for the soothing of Neonatal Abstinence Syndrome (NAS) babies.
The FDA-cleared medical device improves premature infant’s ability to suck efficiently, and feed with improved quality.
According to firm’s clinical studies and scientific research, the premature infants receiving PAL therapy experience earlier removal of feeding tubes, earlier transition to oral feeding, more rapid weight gain and decreased stress.
Powers Medical Devices CEO Patricia Palmer said: "Premature infants come into this world before they have a chance to achieve a major developmental milestone on which their survival depends – the ability to feed."
The Institute CEO Jamie Grooms said that Powers is addressing serious issues facing babies who are born prematurely.
"The FDA-cleared PAL® system not only encourages and reinforces proper feeding skills but also diminishes behavioral stress, resulting in improved overall well-being for infants and their families," added Grooms.
